PlainRecalls
FDA Drug Low Class III Terminated

Maximum Strength Comtrex Nighttime Cold & Cough, Acetaminophen 325mg ,Chlorpheniramine Maleate 2mg, Dextromethorphan HBR 10mg,Phenylephrine HCL 5mg, packaged in 24 coated caplets nighttime formula *includes antihistamine, Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ 075054-0622, NDC 0067-2081-24.

Reported: January 22, 2014 Initiated: May 15, 2013 #D-739-2014

Product Description

Maximum Strength Comtrex Nighttime Cold & Cough, Acetaminophen 325mg ,Chlorpheniramine Maleate 2mg, Dextromethorphan HBR 10mg,Phenylephrine HCL 5mg, packaged in 24 coated caplets nighttime formula *includes antihistamine, Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ 075054-0622, NDC 0067-2081-24.

Reason for Recall

Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing.

Details

Recalling Firm
Novartis Consumer Health
Units Affected
32,256/24-caplet packages
Distribution
Distribution was made nationwide and foriegn distribution was made--Mexicio, Panama, Ecuador and Venezuela.
Location
Lincoln, NE

Frequently Asked Questions

What product was recalled?
Maximum Strength Comtrex Nighttime Cold & Cough, Acetaminophen 325mg ,Chlorpheniramine Maleate 2mg, Dextromethorphan HBR 10mg,Phenylephrine HCL 5mg, packaged in 24 coated caplets nighttime formula *includes antihistamine, Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ 075054-0622, NDC 0067-2081-24.. Recalled by Novartis Consumer Health. Units affected: 32,256/24-caplet packages.
Why was this product recalled?
Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 22, 2014. Severity: Low. Recall number: D-739-2014.